All In MedTech

FDA Clearance Tracker · P210032-S007

GORE TAG Thoracic Branch Endoprosthesis (TBE Device)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 2, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplementBreakthrough

Decided

May 2, 2023

Approved

Time to decision

84 days

Received Feb 7, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P210032-S007
Device name
GORE TAG Thoracic Branch Endoprosthesis (TBE Device)
Applicant location
Flagstaff, AZ
Received
Feb 7, 2023
Decided
May 2, 2023
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P210032

Device type

Device class
Class III

Every decision under product code MIH

FDA's approval statement

As written in FDA's record.

Approval for an expansion of the indications for use and modifications to the Instructions for Use of the Gore TAG Thoracic Branch Endoprosthesis (TBE Device).

Source documents

Other decisions for W. L. Gore & Associates, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.